InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Sunday, 03/27/2022 4:18:22 PM

Sunday, March 27, 2022 4:18:22 PM

Post# of 14947
If you have an extra 17.5 minutes you may want to listen to Dr.Ji being interviewed on Benzinga. The interviewer tries to press Dr.Ji on timelines...but I think Henry has learned not to over promise! Here are a few things that stood out to me.
It is clear that SEMDEXA could be approved late 2022 or early 2023.
And the powerful COVISHIELD nAB could be approved in Q4 2022.
And the oral antiviral Mpro will be in the clinic in April 2022.
And COVIMARK approvals are being sought in US, Canada and CHINA!
You can hear it from the 10:30 to 28:00 mark.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News